Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bordetella pertussis is a small, Gram-negative, encapsulated coccobacillus bacterium that is the causative agent of whooping cough (pertussis), a highly contagious respiratory disease found only in humans. The bacteria attach to the cilia lining the upper respiratory tract, releasing toxins that damage these cells and cause airway inflammation. Key virulence factors include Pertussis toxin (PT), Adenylate cyclase toxin (ACT), Filamentous hemagglutinin (FHA), Pertactin (PRN), Fimbriae/Fimbrial agglutinogens (FIM/AGG), and Tracheal cytotoxin (TCT).
Antibiotic targeting bacterial growth and protein synthesis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bordetella pertussis (whole organism) (B. pertussis).